141 related articles for article (PubMed ID: 7466028)
1. [Progress in medical oncology: introduction].
Klastersky J
Rev Med Brux; 1980 May; 1(5):295-7. PubMed ID: 7466028
[No Abstract] [Full Text] [Related]
2. Cancer treatment research: the role of the nurse in clinical trials of cancer therapy.
Hubbard SM
Nurs Clin North Am; 1982 Dec; 17(4):763-83. PubMed ID: 6757874
[No Abstract] [Full Text] [Related]
3. [Prospects and fata morgana in clinical oncology].
Zwaveling A
Ned Tijdschr Geneeskd; 1980 Jun; 124(24):978-85. PubMed ID: 7383219
[No Abstract] [Full Text] [Related]
4. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
5. Pediatric oncology: past, present, and new modalities of treatment.
Bertolone K
J Intraven Nurs; 1997; 20(3):136-40. PubMed ID: 9214925
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in medical oncology--1995-1996.
Sikov WM
Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
[No Abstract] [Full Text] [Related]
7. [Current trends in clinical chemotherapy of tumors].
Garan AM
Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
[No Abstract] [Full Text] [Related]
8. What's new in surgical oncology.
Norton JA
J Am Coll Surg; 1996 Feb; 182(2):122-9. PubMed ID: 8564043
[No Abstract] [Full Text] [Related]
9. [The current potentials and outlook for drug therapy in oncology].
Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
[No Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring in oncology: does it have a future?
McMahon G; O'Connor R
Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
[No Abstract] [Full Text] [Related]
11. Personalized cancer therapy--the key to the future.
Sikora K
Pharmacogenomics; 2004 Apr; 5(3):225-8. PubMed ID: 15102537
[No Abstract] [Full Text] [Related]
12. [Medical oncology trends].
Aapro MS
Rev Med Suisse; 2008 Jan; 4(140):127-38. PubMed ID: 18309876
[TBL] [Abstract][Full Text] [Related]
13. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
[No Abstract] [Full Text] [Related]
14. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
15. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease.
Hobson K
US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442
[No Abstract] [Full Text] [Related]
16. [New perspectives in cancer treatment].
Brugarolas A; Giráldez J
Rev Med Univ Navarra; 1998; 42(3):127-33. PubMed ID: 10420935
[No Abstract] [Full Text] [Related]
17. [Progress in medical oncology 2012].
Aapro M
Rev Med Suisse; 2013 Jan; 9(369):115-8. PubMed ID: 23409648
[TBL] [Abstract][Full Text] [Related]
18. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
Shpilberg O; Ben-Bassat I; Raanani P
Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
[TBL] [Abstract][Full Text] [Related]
19. [40 years of progress in oncology].
Rouëssé J
Pathol Biol (Paris); 2000 Nov; 48(9):799-800. PubMed ID: 11141914
[No Abstract] [Full Text] [Related]
20. Development trends for monoclonal antibody cancer therapeutics.
Reichert JM; Valge-Archer VE
Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]